| Literature DB >> 28924058 |
Daniel Rossbach1, D Suzi Bryan1, Jay R Hesselberth1, Robert Sclafani2.
Abstract
DDK, a conserved serine-threonine protein kinase composed of a regulatory subunit, Dbf4, and a catalytic subunit, Cdc7, is essential for DNA replication initiation during S phase of the cell cycle through MCM2-7 helicase phosphorylation. The biological significance of DDK is well characterized, but the full mechanism of how DDK associates with substrates remains unclear. Cdc7 is bound to chromatin in the Saccharomyces cerevisiae genome throughout the cell cycle, but there is little empirical evidence as to specific Cdc7 binding locations. Using biochemical and genetic techniques, this study investigated the specific localization of Cdc7 on chromatin. The Calling Cards method, using Ty5 retrotransposons as a marker for DNA-protein binding, suggests Cdc7 kinase is preferentially bound to genomic DNA known to replicate early in S phase, including centromeres and origins of replication. We also discovered Cdc7 binding throughout the genome, which may be necessary to initiate other cellular processes, including meiotic recombination and translesion synthesis. A kinase dead Cdc7 point mutation increases the Ty5 retrotransposon integration efficiency and a 55-amino acid C-terminal truncation of Cdc7, unable to bind Dbf4, reduces Cdc7 binding suggesting a requirement for Dbf4 to stabilize Cdc7 on chromatin during S phase. Chromatin immunoprecipitation demonstrates that Cdc7 binding near specific origins changes during S phase. Our results suggest a model where Cdc7 is loosely bound to chromatin during G1 At the G1/S transition, Cdc7 binding to chromatin is increased and stabilized, preferentially at sites that may become origins, in order to carry out a variety of cellular processes.Entities:
Keywords: calling cards; chromatin; kinase; origins; replication
Mesh:
Substances:
Year: 2017 PMID: 28924058 PMCID: PMC5677158 DOI: 10.1534/g3.117.300223
Source DB: PubMed Journal: G3 (Bethesda) ISSN: 2160-1836 Impact factor: 3.154
S. cerevisiae strains used
| Yeast Strain | Genotype | Background/Reference |
|---|---|---|
| RSY302 | A364a/ | |
| RSY452 | A364a | |
| RSY1294 | W303 | |
| RSY1352 | YM7635 (pBM5249) (pRAS746) | S288C |
| RSY1354 | YM7635 (pBM5249) | S288C |
| DRY101 | YM7635 (pBM5249) (pDR001) | S288C |
| DRY106 | RSY1294 (pCH766) | S288C |
| DRY107 | RSY1294 (pCH777) | S288C |
| DRY110 | YM7635 (pBM5249) (pBM4607) | S288C |
| DRY113 | YM7635 (pBM5249) (pDR011) | S288C |
| DRY126 | YM7635 (pBM5249) (pDR016) | S288C |
| YM7635 | S288C/ |
Recombinant plasmids used
| Plasmid | Genotype | Reference |
|---|---|---|
| pBM4607 | ||
| pBM5249 | ||
| pCH766 | ||
| pCH777 | ||
| pDR001 | This study | |
| pDR011 | This study | |
| pDR016 | This study | |
| pRAS746 | This study | |
| pRS277 |
Primer sequences
| Primer | Sequence |
|---|---|
| (A) Cdc7-Sir4 Fusion Forward | |
| (B) Cdc7-Sir4 Fusion Reverse | |
| (C) Cdc7-Sir4 C-terminal deletion Fusion Reverse | |
| (D) Inverse PCR Forward Primer (OM8714) | |
| (E) Inverse PCR Illumina TruSeq Index Primer 1 (OM8827) | |
| (F) Inverse PCR Illumina TruSeq Index Primer 2 | |
| (G) Inverse PCR Illumina TruSeq Index Primer 3 | |
| (H) Inverse PCR Illumina TruSeq Index Primer 4 | |
| (I) PE Read 2 Illumina Sequencing Primer | |
| (J) Cdc7 N168A Forward | |
| (K) Cdc7 N168A Reverse | |
| (L) Fusion Verification Forward Primer (OM6189) | |
| (M) Fusion Verification Reverse Primer (OM6373) | |
| (N) ARS306 Forward | |
| (O) ARS306 Reverse | |
| (P) ARS607 Forward | |
| (Q) ARS607 Reverse | |
| (R) ARS305 + 8 kb Forward | |
| (S) ARS305 + 8 kb Reverse | |
| (T) ARS1 + 10 kb Forward | |
| (U) ARS1 + 10 kb Reverse |
Figure 1Calling Cards construct efficiency. (A) GAL4 open reading frame fused to the sir4 domain that interacts with Ty5 integrase. This construct was donated to us by David Mayhew (Washington University in St. Louis). (B) Full length CDC7 (507 aa) was inserted into the GAL4-sir4-myc plasmid backbone to create sir4-fusion. (C) SLD3 fused to sir4. (D) Full length cdc7KD (507 aa) fused to sir4 contains a N168A kinase dead point mutation. (E) cdc7KDΔCT fused to sir4 contains same N168A mutation and additionally lacks 55 C-terminal residues. (F) Yeast strain containing Ty5 transposon donor plasmid was transformed with the indicated DNA replication factor fusion constructs and tested for efficiency to integrate Ty5 transposons into genomic DNA by measuring the relative amount of His+ 5FOA resistant cells, in which transposition occurred.
Figure 2Calling Cards sequences mapped to S. cerevisiae genome. Ty5 transposons integrated by DNA replication factor fusion constructs were isolated, sequenced, and mapped to the yeast genome. Chromosome 4 from the UCSC genome browser is used to show where Ty5 transposon integration marks occur for each DNA replication factor fusion construct. Orc1 and Mcm2 chromatin immunoprecipitation (Xu ) and replication timing (Yabuki ) are plotted for reference. (A) Calling Cards signal at each position normalized to the number of aligned reads in the library (reads per million, RPM). The X-axis and vertical lines represent Ty5 transposon integration events at specific positions within the chromosome and the y-axis and height of each line is the normalized signal at each position. (B) Normalized to mean number of unique insertions events. Removes quantitative information and only displays unique position of insertion events in the genome.
Figure 3Ty5 transposons from Cdc7 insert into early replicating DNA. Ty5 transposon integrations are compared to timing of replication of the genome. Replication timing microarray data sets were used (Raghuraman ). The genome was divided into 5-min windows based on the overall timing of replication. Each box is a representation of the Calling Cards signal of a given construct in a specific replication timing window. Calling Cards signal at each position was normalized to the number of aligned reads in the library (reads per million, RPM). The X-axis and vertical lines represent Ty5 transposon integration events at specific positions within the chromosome and the y-axis and height of each line is the normalized signal at each position. (A) RPM signal comparing each fusion construct to negative control Ty5 integrations. (B) RPM signal comparing Cdc7 fusion constructs to Gal4 fusion construct. (C) RPM signal comparing cdc7KD-sir4 fusion construct to cdc7KDΔCT-sir4 fusion construct. Calling Cards was normalized to mean number of unique insertions events. (D) Mean number of unique insertions comparing each fusion construct to negative control Ty5 integrations. (E) Mean number of unique integrations comparing Cdc7 fusion constructs to Gal4 fusion construct. (F) Mean number of unique integrations comparing cdc7KD-sir4 fusion construct to cdc7KDΔCT-sir4 fusion construct. Statistical analysis was done using the nonparametric Wilcoxon test as we were not convinced our data followed a normal distribution. *P = 0.01–0.05; ** P = 0.001–0.01; *** P < 0.001; NS, not significant.
Figure 4Ty5 insertions integrate preferentially near ACS sites. Ty5 transposon insertions are compared to known ACS sites within the genome. A 1-kb window on either side of ACS sites was used to determine where Cdc7-directed integrations occur in relation to the ACS. (A) Calling Cards insertions signal compared to confirmed/likely ACS sites normalized to the number of aligned reads in the library (reads per million, RPM). The x-axis is the position relative to ACS sites and y-axis is the normalized signal. (B) Calling Cards insertions signal compared to dubious ACS sites normalized to the number of aligned reads in the library (RPM). (C) Calling Cards insertions compared to confirmed/likely ACS sites normalized to the mean number of unique insertions where the x-axis is the position relative to ACS sites and y-axis is the mean number of insertions for a given genomic position. (D) Calling Cards insertions compared to dubious ACS sites normalized to mean number of unique insertions.
Figure 5Ty5 transposons do not correlate with Orc1 binding sites. Ty5 transposon insertions compared to Orc1 binding sites. A 5-kb window on either side of all Orc1 binding sites was used to determine where integrations occur in relation to protein markers of replication. (A) Calling Cards insertions compared to Orc1 binding sites normalized to the number of aligned reads in the library (reads per million, RPM). The x-axis is the position relative to Orc1 binding sites and the y-axis is the normalized signal. (B) Calling Cards insertions compared to Orc1 binding sites normalized to mean number of unique insertions at a given position.
Figure 6Chromatin immunoprecipitation (ChIP) analysis of Cdc7 at origins of replication. ChIP in strains overexpressing wild-type or kinase dead Cdc7 and strains lacking overexpression was performed on cells released from G1 arrest through S phase using an anti-HA antibody or no antibody negative control. Chromatin associated DNA was analyzed using quantitative PCR for specific DNA segments. (A) Flow cytometry analysis of wild-type and kinase dead Cdc7 overexpression plasmids. (B) ChIP analysis of wild-type Cdc7 using primers specific to origins of replication in a strain with overexpression or no overexpression. (C) Similar ChIP analysis of wild-type Cdc7 using primers specific to genomic regions 10 kb distant from ARS1 and 8 kb distant from ARS305. (D) ChIP analysis of kinase dead Cdc7 using primers specific to origins of replication in strains with or without overexpression. (E) ChIP analysis of kinase dead Cdc7 using primers specific to genomic regions distant from origins.
Figure 7Model of Cdc7 action during DNA replication. Cdc7 protein is bound to chromatin throughout the genome during G1 phase of the cell cycle in the absence of Dbf4 protein. As Dbf4 protein expression increases, Cdc7 protein is stabilized on chromatin throughout the genome and is preferentially bound to known ACS sites. Increases in binding increase the potential to phosphorylate substrates including minichromosome maintenance (MCM) helicase complexes. Phosphorylation of the MCM complexes by Cdc7-Dbf4 kinase (DDK) results in loading of Cdc45 and GINS to form the active MCM helicase and to load on the replisome, which replicates the DNA. DDK not bound preferentially to ACS sites is used to promote TLS, meiotic recombination, and chromatid cohesion.